Update on the Glasgow to Edinburgh Canoe Challenge 2017
Kidney Cancer Scotland had a great meeting with the Glasgow to Edinburgh Canoe Challenge 2017 (#Glas2Ed2017) organisers this week and it’s really... Read More
Kidney Cancer UK aiming to help close the gap between Europe & UK in cancer diagnosis & treatment.
In the Newspapers On July 17, The Independent reported that the UK is lagging behind Europe in the diagnosis and treatment of... Read More
New treatment option: Cabozantinib is now available for use in the NHS for advanced kidney cancer patients
Kidney Cancer UK is delighted that National Institute for Health and Care Excellence (NICE) has recommended the drug cabozantinib (Cabometyx) be made... Read More
Request for Patient Experts
Kidney Cancer UK sends in comment each time new drugs are appraised by the National Institute for Health and Care Excellence (NICE).... Read More
Living with kidney cancer; managing the emotions and feelings
Anyone can have mental health issues; many people do. There are a wide range of emotions and mental health issues and people with,... Read More
Recent developments and future clinical trials for advanced kidney cancer:
immunotherapy and drug combinations including cabozantinib and nivolumab. *You may find our Glossary of Terms useful when reading this article Good news:... Read More
Kidney Cancer UK support letter to CCG’s
Last month I represented Kidney Cancer UK at a meeting in Westminster. The aim of the meeting was to discuss a letter... Read More
Hopes for Cabozantinib NICE recommendation
Kidney Cancer UK is very disappointed to hear that at the midpoint of the Single Technology Appraisal (STA) of cabozantinib, NICE is... Read More
Obesity: a major factor in the UK’s sharp rise in kidney cancer?
Would you like chips with that? A pudding? Another drink? Yes, yes and yes! Eating lavishly: it’s easily done, whether at home... Read More
May 1, Bank Holiday Opening Times
Our office is closed on May 1 Bank Holiday Monday but our Careline will be available as normal. Should you need support,... Read More
Cabozantinib unlikely to be recommended based on cost: NICE and Ipsen in talks
NICE and Ipsen are continuing to discuss whether cabozantinib (Cabometyx) is to be recommended for use on the NHS in England and Wales. Cabozantinib,... Read More
Easter Opening Times
We hope everyone has a happy Easter. Our opening times are as follows: Closed Friday 14 April reopen on Tuesday 18... Read More
Three different appraisals in the pipeline for 2017 from NICE
Earlier this year, Kidney Cancer UK sent comments to the National Institute for Health and Care Excellence (NICE) for three different appraisals. ... Read More
MY STORY…. so far!
By Wendy Pickering Last April I was feeling different, tired and uncomfortable after eating and also tenderness around my sternum. So made... Read More
Mike Tunstall – My Kidney Cancer Story
It all started with a vague pain in my right testicle leading to me making an appointment with my GP in June... Read More
The Britain against cancer conference
By Dr Rebecca Case-Upton Last week Lucy Willingale (Patient information and support leader) and I (Dr Rebecca Case-Upton – medical publications) attended the... Read More
Starving kidney cell tumours of glutamine
Starving kidney cell tumours of glutamine may halt their growth and destroy them. A novel approach currently being investigated. A novel approach... Read More
Nivolumab available on the NHS from mid-December
Nivolumab is due to be available on the NHS from the mid-December. NICE has published the final guidance on the use of... Read More
First-line treatment of advanced kidney cancer look promising
Preliminary results of new combination immunotherapy, for first-line treatment of advanced kidney cancer, look promising. We are extremely pleased that NICE has... Read More
Evaluating the need for kidney cancer screening
By Dr Rebecca Case-Upton BSc (Hons), PhD Medical Publications A positive prognosis for kidney cancer is greatly increased if the disease is... Read More
Linda Johnson – My Snowdon Race, 2016
My name is Linda Johnson and this is the story of My Snowdon Race, 2016 which I ran for Kidney Cancer Scotland.... Read More
New drug cabozantinib for treating advanced kidney cancer under NICE review.
New drug cabozantinib, for use in treating advanced kidney cancer (approved by the FDA in the USA), is currently in the process of... Read More
Change NICE negative nivolumab recommendation; every voice counts
We still have time to change NICE negative nivolumab recommendation. Many of you may be aware that the immunotherapy drug nivolumab is... Read More
NICE give nivolumab NO as initial recommendation
NICE give nivolumab NO as initial recommendation We were all hoping for good news regarding the NICE appraisal of Nivolumab in October,however,... Read More